This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Drexler, H. Articles by Flaim, S. F. Search for Related Content PubMed PubMed Citation Articles by Drexler, H. Articles by Flaim, S. F. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB DILTIAZEM Medline Plus Health Information Heart Attack Heart Failure

Circulation, Vol 71, 1262-1270, Copyright © 1985 by American Heart Association

ARTICLES

Effects of diltiazem on cardiac function and regional blood flow at rest and during exercise in a conscious rat preparation of chronic heart failure (myocardial infarction)

H Drexler, JW Depenbusch, AG Truog, R Zelis and SF Flaim

The effects of intravenous infusion of diltiazem on regional blood flow (radioactive microspheres), hemodynamics, and maximum rate of oxygen consumption were evaluated in conscious rats with congestive heart failure caused by large myocardial infarction (n = 10, infarct size 41.8% of left ventricle) and compared with data obtained from rats subjected to sham surgical procedures (n = 9). In both groups data were obtained at rest and during submaximal treadmill exercise during alternate infusion of diltiazem and saline. In the group with heart failure, diltiazem increased stroke volume at rest and during exercise (p less than .05), reduced heart rate (p less than .05), and improved cardiac output during exercise (p less than .05) without increasing left ventricular end-diastolic pressure in any of the animals. Blood flow to renal and splanchnic circulations was reduced in the group with heart failure but was increased by diltiazem to values similar to those observed in sham-operated animals. Although skeletal muscle flow during exercise was significantly increased by the drug, maximal rate of oxygen consumption was not, indicating unchanged oxygen availability within working muscle. Thus diltiazem caused redistribution of blood flow to kidney and gut in animals with myocardial infarction and failure, thereby restoring blood flow to circulatory beds known to be impaired in this setting.

This article has been cited by other articles:

				N. S. Dhalla, M. R. Dent, P. S. Tappia, R. Sethi, J. Barta, and R. K. Goyal Subcellular Remodeling as a Viable Target for the Treatment of Congestive Heart Failure Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2006; 11(1): 31 - 45. [Abstract] [PDF]

				R Sharma and S.D Anker From tissue wasting to cachexia: changes in peripheral blood flow and skeletal musculature Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D12 - D17. [Abstract] [PDF]

				D. Grimm, D. Elsner, H. Schunkert, M. Pfeifer, D. Griese, G. Bruckschlegel, F. Muders, G. A.J Riegger, and E. P Kromer Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system Cardiovasc Res, January 1, 1998; 37(1): 91 - 100. [Abstract] [Full Text] [PDF]

				B. C.G. Gho, R. G. Schoemaker, M. A. van den Doel, D. J. Duncker, and P. D. Verdouw Myocardial Protection by Brief Ischemia in Noncardiac Tissue Circulation, November 1, 1996; 94(9): 2193 - 2200. [Abstract] [Full Text]

				R. Yang, S. Bunting, N. Gillett, R. Clark, and H. Jin Growth Hormone Improves Cardiac Performance in Experimental Heart Failure Circulation, July 15, 1995; 92(2): 262 - 267. [Abstract] [Full Text]